| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.006 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.13 | 0.01 |